Delivery Order HT940622D0002-HT940622F0040
Award Date 7/1/22
Potential Completion Date 9/30/22
Potential Value $64K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92134, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $58,006.25 firm fixed-price purchase order to RLS (USA) Inc. for radiopharmaceuticals and related services to support the Department of Radiology Nuclear Medicine. The contract, awarded on October 1, 2025, with an ultimate completion date of September 30, 2026, represents a non-set-aside procurement for time-sensitive medical isotopes and diagnostic imaging agents required for nuclear medicine procedures at military treatment facilities. RLS (USA) Inc., a...
- RLS (USA) Inc., a radiopharmacy company headquartered in Lake Mary, Florida, was awarded a $204,216.35 firm fixed-price purchase order by the Defense Health Agency on October 1, 2023, as a Total Small Business Set-Aside contract. The award supports radiopharmaceutical supply requirements for the Radiology Department at Naval Hospital Camp Pendleton in California. The contract calls for the delivery of 18 radiopharmaceutical products including diagnostic imaging agents such as gallium-67,...
- The Defense Health Agency awarded a $200,000 firm fixed-price purchase order to RLS (USA) Inc. for radiopharmaceutical products, effective October 1, 2021, with completion targeted for September 30, 2023. This contract carries a Total Small Business set-aside designation and is performed in Tampa, Florida. RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, operates 31 radiopharmacy facilities across 18 states and specializes in supplying nuclear medicine...
- RLS (USA) Inc., a radiopharmacy company headquartered in Lake Mary, Florida, was awarded a delivery order valued at $250,075.29 by the Department of Veterans Affairs' Northern California Health Care System (Veterans Integrated Service Network 21) for radiopharmaceuticals and radiopharmaceutical supplies. The contract, issued on April 1, 2026, with an ultimate completion date of March 31, 2027, utilizes firm fixed-price pricing and is not designated as a set-aside contract. This delivery order...
- RLS (USA) Inc., a foreign-owned radiopharmacy company, has been awarded a delivery order valued at $356,461.75 by the Department of Veterans Affairs Veterans Integrated Service Network 5 for the supply of radiopharmaceuticals. The contract, awarded on April 1, 2025, carries a firm fixed price structure and an ultimate completion date of March 31, 2026. Performance will be executed from the contractor's facility in Lake Mary, Florida. This delivery order does not carry a set-aside designation and...
- This federal contract award to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, is for the provision of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA) and the Defense Health Agency (DHA). The $833,285.36 firm fixed-price purchase order has a performance period ending on June 22, 2023. RLS (USA) Inc. is a small business that specializes in supplying critical molecular imaging products, including medical isotopes and radiopharmaceuticals, to support nuclear...
- RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, was awarded a $1.13 million firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 22 on December 1, 2023, with performance extending through November 30, 2026. The contract, which carries no set-aside designation, calls for the supply of radiopharmaceutical products to support nuclear medicine diagnostic and therapeutic imaging services. The...
- RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, was awarded a firm fixed-price purchase order valued at $882,014.09 by the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 20 on March 1, 2020. The contract, which is set aside for 8(a) small businesses under NAICS code 325412 (Pharmaceutical Preparation Manufacturing), calls for the supply of radiopharmaceuticals to support nuclear medicine diagnostic and therapeutic...
- The Defense Health Agency awarded a purchase order to RLS (USA) Inc. for various radiopharmaceuticals valued at $119,933.60 on October 1, 2024. The order carries a Total Small Business set-aside designation. Performance occurs at 2330 Stanley Road, Fort Sam Houston, Texas. The requirement covers a 12-month supply of radiopharmaceutical products including iodine-131, technetium-99m labeled kits, iodine-123, indium-111 labeled products, xenon-133, and gallium-68/copper-64 labeled products for...
- The Department of Veterans Affairs, Veterans Integrated Service Network 2, awarded a $18,331.68 firm fixed-price delivery order to RLS (USA) Inc. for NETSPOT GA-68 radiopharmaceutical products under Ordering Period 2 of contract BRX 526C50247. This delivery order, effective September 1, 2025, with an ultimate completion date of December 31, 2025, represents a decrease in unused FY25 funds and does not utilize a set-aside designation. The work will be performed in Lake Mary, Florida, where RLS...
- HT940622D0002Indefinite Delivery Contract
- HT940622D0002-HT940622F0040Delivery Order
RLS USA Inc. was awarded a $64,238.93 firm fixed price delivery order against the Defense Health Agency's radiopharmaceuticals contract vehicle to provide unspecified radiopharmaceutical products for use by the agency. Performance will occur in San Diego, California by September 30, 2022. No set-aside provisions were applied to this award to supply the Defense Health Agency's medical programs with the radioactive materials.
Generated 1/3/24, 5:02 PM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Radiopharmaceuticals-NMCSD | N6264521R0050 | Department of the Navy Naval Supply Systems Command | Solicitation 2/2 | 9/29/21, 10:34 AM | |
Radiopharmaceuticals-NMCSD | Radiopharmaceuticals-NMCSD | Department of the Navy Naval Supply Systems Command | Pre-Solicitation 1/2 | 9/9/21, 1:50 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Supplemental Agreement for work within scope | ($300k) | 11/7/22 | |
| P00001 | Other Administrative Action | $0 | 7/13/22 | |
| Not listed | Not listed | $364.2k | 6/30/22 |